Application of MRI in patients with non-alcoholic fatty liver disease
Not Applicable
- Conditions
- Diseases of the digestive system
- Registration Number
- KCT0004307
- Lead Sponsor
- Hanyang University Seoul Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Male or female confirmed as fatty liver by imaging test within 6 months from 19 to 75 years
Exclusion Criteria
Those who lost more than 10% of their previous weight within 6 months.
Those who have received diet or exercise therapy that may affect the results of human testing within 3 months of screening.
HBsAg, HCVAb positive factor. Those who have accompanying diseases such as eating disorders (anorexia, bulimia)
Those who have received drugs or diuretics, amphetamine, cyproheptadine, phenothiazine, appetite suppressants, or appetite enhancers or consumed probiotics within 2 weeks prior to screening.
With hepatic malignant disease and acute systemic inflammation and infection
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method iver fat mass using MRI-PDFF (%)
- Secondary Outcome Measures
Name Time Method Intrahepatic Fibrosis with MR elastography (kPa)